|MMWR Surveillance Summaries|
Vol. 65, No. SS-8
August 5, 2016
Paul Mehta, MD; Wendy Kaye, PhD; Leah Bryan, MPH; et al.
MMWR Surveill Summ 2016;65:1–12
Amyotrophic lateral sclerosis (ALS), commonly known as Lou Gehrig’s disease, is a progressive and fatal neuromuscular disease for which no cure or viable treatment has been identified. The National ALS Registry, established in 2009, collects data on ALS patients in the United States to better describe the incidence and prevalence of ALS, examine risk factors such as environmental and occupational exposures, and characterize the demographics of those living with ALS. This report updates the initial Registry findings regarding ALS prevalence for the period October 19, 2010–December 31, 2011 and presents new findings for 2012–2013. The intended audience for this report comprises public health officials, clinicians, and researchers working to better understand ALS etiology and address the needs of persons with ALS and their families.
Prevalence of Amyotrophic Lateral Sclerosis — United States, 2012–2013 | MMWR